These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 986115)
1. Immunocytologic losses of isoantigens A, B, and H (O) in the endometrium and brain. Gupta RK Am J Clin Pathol; 1976 Aug; 66(2):390-4. PubMed ID: 986115 [TBL] [Abstract][Full Text] [Related]
2. Loss of isoantigens A, B and H in prostate. Gupta RK; Schuster R; Christian WD Am J Pathol; 1973 Mar; 70(3):439-47. PubMed ID: 4120302 [TBL] [Abstract][Full Text] [Related]
3. Isoantigens A, B and H in benign and malignant lesions of breast. Gupta RK; Schuster R Am J Pathol; 1973 Aug; 72(2):253-7. PubMed ID: 4807589 [TBL] [Abstract][Full Text] [Related]
4. Human milk-fat globule membrane antigens (Mam-3 group) in normal cycling endometrium and endometrial carcinomas--an immunohistochemical study. A preliminary report. Ravn V; Jensen H; Hilgers J APMIS; 1989 May; 97(5):452-8. PubMed ID: 2659045 [TBL] [Abstract][Full Text] [Related]
5. Expression of blood group antigens and lectin binding in adenocarcinomas of the endometrium. Memon RS; Yonezawa S; Hasui K; Sato E Acta Pathol Jpn; 1990 Jul; 40(7):509-16. PubMed ID: 2220398 [TBL] [Abstract][Full Text] [Related]
6. Distribution of epithelial membrane antigen in normal and abnormal endometrial tissue. Morse AR; Curran GJ Br J Obstet Gynaecol; 1985 Dec; 92(12):1286-90. PubMed ID: 3910081 [TBL] [Abstract][Full Text] [Related]
7. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors. Skovlund VR APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838 [TBL] [Abstract][Full Text] [Related]
8. Expression of type-2 histo-blood group carbohydrate antigens (Le(x), Le(y), and H) in normal and malignant human endometrium. Ravn V; Mandel U; Svenstrup B; Dabelsteen E Virchows Arch; 1994; 424(4):411-9. PubMed ID: 8205354 [TBL] [Abstract][Full Text] [Related]
9. The expression of Ca antigen in normal, hyperplastic and neoplastic endometrium. Ferguson AM; Fox H Br J Obstet Gynaecol; 1984 Oct; 91(10):1042-5. PubMed ID: 6386039 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues. Thor A; Viglione MJ; Muraro R; Ohuchi N; Schlom J; Gorstein F Int J Gynecol Pathol; 1987; 6(3):235-47. PubMed ID: 3429107 [TBL] [Abstract][Full Text] [Related]
11. Expression of blood group antigens A, B, H, Lewis-a, and Lewis-b in fetal, normal, and malignant tissues of the uterine endometrium. Inoue M; Sasagawa T; Saito J; Shimizu H; Ueda G; Tanizawa O; Nakayama M Cancer; 1987 Dec; 60(12):2985-93. PubMed ID: 3677023 [TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of blood group-related antigens in uterine endometrial cancers. Tsukazaki K; Sakayori M; Arai H; Yamaoka K; Kurihara S; Nozawa S Jpn J Cancer Res; 1991 Aug; 82(8):934-41. PubMed ID: 1910029 [TBL] [Abstract][Full Text] [Related]
13. Immunohistological study of isoantigens, carcinoembryonic antigen and human chorionic gonadotropin in adenocarcinomas of the uterus. Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Inoue Y; Saito J; Nishino T; Kurachi K Nihon Sanka Fujinka Gakkai Zasshi; 1984 Mar; 36(3):437-42. PubMed ID: 6715926 [TBL] [Abstract][Full Text] [Related]
14. [Altered expression of Lewis antigens associated with malignant transformation in endometrial tissues]. Inoue M; Sasagawa T; Shimizu C; Shimizu H; Saito J; Ueda G; Tanizawa O; Nakayama M Nihon Sanka Fujinka Gakkai Zasshi; 1988 Sep; 40(9):1425-31. PubMed ID: 3049851 [TBL] [Abstract][Full Text] [Related]
15. Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system. Kumar S; Taylor G; Steward JK; Waghe MA; Morris-Jones P Int J Cancer; 1973 Jul; 12(1):194-205. PubMed ID: 4364270 [No Abstract] [Full Text] [Related]
16. Expression of CAR-3 and TAG-72 macromolecules in normal and transformed endometrium: potential diagnostic application in postmenopausal patients. Bartolazzi A; Mottolese M; Vocaturo A; Bigotti A; Vocaturo G; Atlante G; Prat M; Natali PG Cancer Res; 1991 Jun; 51(11):3001-5. PubMed ID: 2032237 [TBL] [Abstract][Full Text] [Related]
17. Tissue CEA test in endocervical and endometrial adenocarcinoma. Wahlström T; Seppälä M Lancet; 1980 Mar; 1(8168 Pt 1):597. PubMed ID: 6102317 [No Abstract] [Full Text] [Related]
18. [Detection of tumors specific humoral anitbody against brain tumors (author'stransl)]. Shimizu T; Kito K; Kubota S; Kitamura K; Takakura K No Shinkei Geka; 1974; 2(11-12):747-56. PubMed ID: 4376831 [No Abstract] [Full Text] [Related]
19. Are blood group isoantigens lost from malignant prostatic epithelium? Immunohistochemical support for the preservation of the H isoantigen. Vowden P; Lowe AD; Lennox ES; Bleehen NM Br J Cancer; 1986 Mar; 53(3):307-12. PubMed ID: 2421753 [TBL] [Abstract][Full Text] [Related]
20. Identification of an H antigen-like blood group antigen in sera of cancer patients using a novel monoclonal antibody raised against endometrial carcinoma. Tsuji Y; Yoshioka M; Ogasawara T; Takemura T; Isojima S Cancer Res; 1987 Jul; 47(13):3543-50. PubMed ID: 2438039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]